| Net loss | -2.1M |
| Depreciation | 69K |
| Amortization of patents | 0 |
| Employee share-based compensation | 8K |
| Amortization of discount on notes payable | 0 |
| Amortization of deferred loan costs | 0 |
| Common shares issued for interest on outstanding debt | |
| Loss on derivative liability | 0 |
| Operating assets | 343K |
| Operating liabilities | 125K |
| Net cash flows from operating activities before reorganization items | |
| Gain on reorganization plan | |
| Change in accrued professional fees | |
| Change in provision for indemnity agreements | |
| Net change in cash flows from reorganization items | |
| Net cash flows from operating activities | |
| Purchase of property and equipment | -75K |
| Net cash flows from investing activities | |
| Repayment of notes payable and long-term debt | -3K |
| Advances (to) from related party | 700K |
| Issuance of long-term debt | |
| Proceeds from exercise of stock options | |
| Payment of deferred financing costs | |
| Net cash flows from financing activities | |
| Net change in cash | -201K |
| Cash at beginning of period | |
| Cash at end of period | |
| Issuance of warrants | |
| Issuance of shares for payment of principal and interest on outstanding debt | 0 |
| Issuance of shares to settle pre-petition claims | |
| Cumulative effect of change in accounting principle | |
| Cash paid for interest during period | 2K |